The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Open accessAbstract
Current genome-editing technologies introduce double-stranded (ds) DNA breaks at a target locus as the first step to gene correction. Although most genetic diseases arise from point mutations, current approaches to point mutation correction are inefficient and typically induce an abundance of random insertions and deletions (indels) at the target locus resulting from the cellular response to dsDNA breaks. Here we report the development of 'base editing', a new approach to genome editing that enables the direct, irreversible conversion of one target DNA base into another in a programmable manner, without requiring dsDNA backbone cleavage or a donor template. We engineered fusions of CRISPR/Cas9 and a cytidine deaminase enzyme that retain the ability to be programmed with a guide RNA, do not induce dsDNA breaks, and mediate the direct conversion of cytidine to uridine, thereby effecting a C→T (or G→A) substitution. The resulting 'base editors' convert cytidines within a window of approximately five nucleotides, and can efficiently correct a variety of point mutations relevant to human disease. In four transformed human and murine cell lines, second- and third-generation base editors that fuse uracil glycosylase inhibitor, and that use a Cas9 nickase targeting the non-edited strand, manipulate the cellular DNA repair response to favour desired base-editing outcomes, resulting in permanent correction of ~15-75% of total cellular DNA with minimal (typically ≤1%) indel formation. Base editing expands the scope and efficiency of genome editing of point mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The discovery of spontaneous hydrolytic deamination of cytosine converting C-G base pairs to T-A in humans highlighted the potential of base editing for direct base pair conversion without requiring double-strand breaks or homology repair templates (Komor, et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor, et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the same paper, with enhanced third-generation base editors, Komor et al. achieved >30-fold greater editing efficiency in various human cell lines when compared to HDR-mediated Cas9 editing, with fewer indel formation.”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [82]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“First-generation base editors had limitations such as low efficiency and base excision repair (BER) activity that reversed edits (Komor et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Second-generation editors, such as APOBEC-XTEN-dCas9-UGI, added an uracil DNA glycosylase inhibitor (UGI) to improve C-to-T conversion (Komor et al., 2016) but still had <0.1% indel formation, limiting precision (Azameti and Dauda, 2021).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Fusion of a cytidine deaminase (rAPOBEC1) to a partially inactive nickase-Cas9(D10A) protein results in a cytidine base editor (CBE) that allows for C > T base changes via a uracil intermediate28”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Coupling this Cas9n or dCas9, the catalytically “dead” variant of Cas9, with a cytidine deaminase enzyme enables the gRNA-mediated deamination of cytosine (C) bases in the non-target DNA strand into uracil (U), which shares the base-pairing properties of thymine (T) [82].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [82]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
Experimental — accuracy not yet measuredIn the citing paper
“Variations on these methods enable the functional evaluation of genes (via knockout screens124), regulatory elements (using CRISPR interference and CRISPR activation screens125,126), and genetic variants (base editors127) at increasing scale and resolution29.”
From A brief history of human disease genetics (2020) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Cited by
Sorted by citations
Items 501–600 of 1,035
Wang, Y., Cheng, H., Liu, Y., Liu, Y., Xiao, W., Zhang, K., Ni, X., Gao, N., Fan, L., Zhang, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21003-y · Cited by 108
Engineered prime editors with PAM flexibility
Kweon, J., Yoon, J.-K., Jang, A.-H., Shin, H. R., See, J.-E., Jang, G., Kim, J., & Kim, Y. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.02.022 · Cited by 111
Self-citationStructure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins
Jia, N., & Patel, D. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00371-9 · Cited by 115
Mukai, H., Ogawa, K., Kato, N., & Kawakami, S. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100450 · Cited by 108
Genome engineering via gene editing technologies in microalgae
Jeong, B., Jang, J.-H., & Jin, E. (2023) · Bioresource Technology · doi:10.1016/j.biortech.2023.128701 · Cited by 108
Strand-selective base editing of human mitochondrial DNA using mitoBEs
Yi, Z., Zhang, X., Tang, W., Yu, Y. F., Wei, X., Zhang, X., & Wei, W. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01791-y · Cited by 112
CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling
Liu, J., Zhou, Y., Qi, X., Chen, J., Chen, W., Qiu, G., Wu, Z., & Wu, N. (2016) · Human Genetics · doi:10.1007/s00439-016-1739-6 · Cited by 110
Hybridization Kinetics Explains CRISPR-Cas Off-Targeting Rules
Klein, M., Eslami-Mossallam, B., Arroyo, D. G., & Depken, M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.045 · Cited by 113
Efficient, continuous mutagenesis in human cells using a pseudo-random DNA editor
Chen, H., Liu, S., Padula, S., Lesman, D., Griswold, K., Lin, A. Z., Zhao, T., Marshall, J. L., & Chen, F. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0331-8 · Cited by 107
Comparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies
Castro, N. G. G., Bjelic, J., Malhotra, G., Huang, C., & Alsaffar, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910355 · Cited by 110
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges
Kalter, N., Fuster‐García, C., Silva, A., Ronco-Díaz, V., Roncelli, S., Turchiano, G., Gorodkin, J., Cathomen, T., Benabdellah, K., Lee, C. M., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102636 · Cited by 121
In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA
Villiger, L., Rothgangl, T., Witzigmann, D., Oka, R., Lin, P. J. C., Qi, W., Janjuha, S., Berk, C., Ringnalda, F., Beattie, M. B., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00671-z · Cited by 105
Tools for experimental and computational analyses of off-target editing by programmable nucleases
Bao, X. R., Pan, Y., Lee, C. M., Davis, T. H., & Bao, G. (2021) · Nature Protocols · doi:10.1038/s41596-020-00431-y · Cited by 106
Novel features and considerations for ERA and regulation of crops produced by genome editing
Duensing, N., Sprink, T., Parrott, W. A., Fedorova, M., Lema, M. A., Wolt, J. D., & Bartsch, D. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00079 · Cited by 106
Continuous directed evolution of proteins with improved soluble expression
Wang, T., Badran, A. H., Huang, T. P., & Liu, D. R. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0121-5 · Cited by 106
Self-citationEckerstorfer, M. F., Dolezel, M., Heissenberger, A., Miklau, M., Reichenbecher, W., Steinbrecher, R. A., & Waßmann, F. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00031 · Cited by 107
She, K., Liu, Y., Zhao, Q., Jin, X., Yang, Y., Su, J., Li, R., Song, L., Xiao, J., Yao, S., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01234-1 · Cited by 106
Kong, X., Zhang, H., Li, G., Wang, Z., Kong, X., Wang, L., Xue, M., Zhang, W., Wang, Y., Lin, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37829-7 · Cited by 110
Programmable Genome Editing Tools and their Regulation for Efficient Genome Engineering
Guha, T. K., Wai, A., & Hausner, G. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.12.006 · Cited by 117
Progress in Genome Editing Technology and Its Application in Plants
Zhang, K., Raboanatahiry, N. H., Zhu, B., & Li, M. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.00177 · Cited by 105
CRISPR-based genomic tools for the manipulation of genetically intractable microorganisms
Shapiro, R. S., Chavez, A., & Collins, J. J. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0002-7 · Cited by 107
CRISPR technologies for stem cell engineering and regenerative medicine
Hsu, M., Chang, Y., Truong, V. A., Lai, P., Nguyen, T. K. N., & Hu, Y. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107447 · Cited by 106
Signaling cascades in the failing heart and emerging therapeutic strategies
He, X., Du, T., Long, T., Liao, X., Dong, Y., & Huang, Z. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00972-6 · Cited by 108
Emerging Gene Therapies for Genetic Hearing Loss
Ahmed, H., Shubina-Oleinik, O., & Holt, J. R. (2017) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-017-0634-8 · Cited by 105
Basics of genome editing technology and its application in livestock species
Petersen, B. (2017) · Reproduction in Domestic Animals · doi:10.1111/rda.13012 · Cited by 103
Transforming plant biology and breeding with CRISPR /Cas9, Cas12 and Cas13
Schindele, P., Wolter, F., & Puchta, H. (2018) · FEBS Letters · doi:10.1002/1873-3468.13073 · Cited by 110
Gene editing technologies and applications for insects
Gantz, V. M., & Akbari, O. S. (2018) · Current Opinion in Insect Science · doi:10.1016/j.cois.2018.05.006 · Cited by 104
Improving CRISPR Genome Editing by Engineering Guide RNAs
Moon, S. B., Kim, D. Y., Kim, J., Kim, J., & Kim, Y.-S. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.01.009 · Cited by 106
Self-citationPrinciples of Genetic Engineering
Lanigan, T. M., Kopera, H. C., & Saunders, T. L. (2020) · Genes · doi:10.3390/genes11030291 · Cited by 114
A versatile genetic engineering toolkit for E. coli based on CRISPR-prime editing
Tong, Y., Jørgensen, T. S., Whitford, C. M., Weber, T., & Lee, S. Y. (2021) · Nature Communications · doi:10.1038/s41467-021-25541-3 · Cited by 104
CRISPR-based gene editing technology and its application in microbial engineering
Wei, J., & Li, Y. (2023) · Engineering Microbiology · doi:10.1016/j.engmic.2023.100101 · Cited by 106
Tremblay, F., Xiong, Q., Shah, S. S., Ko, C., Kelly, K., Morrison, M. S., Giancarlo, C., Ramírez, R. N., Hildebrand, E. M., Voytek, S. B., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03508-x · Cited by 116
CRISPR engineering in organoids for gene repair and disease modelling
Geurts, M. H., & Clevers, H. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00013-5 · Cited by 103
Optimizing genome editing strategy by primer-extension-mediated sequencing
Yin, J., Liu, M., Liu, Y., Wu, J., Gan, T., Zhang, W., Li, Y., Zhou, Y., & Hu, J. (2019) · Cell Discovery · doi:10.1038/s41421-019-0088-8 · Cited by 108
Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations
Wang, L., Xue, W., Zhang, H., Gao, R., Qiu, H.-Y., Wei, J., Zhou, L., Lei, Y.-N., Wu, X., Li, X., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00671-4 · Cited by 106
Emerging applications for DNA writers and molecular recorders
Farzadfard, F., & Lu, T. K. (2018) · Science · doi:10.1126/science.aat9249 · Cited by 102
Marquart, K. F., Allam, A., Janjuha, S., Sintsova, A., Villiger, L., Frey, N., Krauthammer, M., & Schwank, G. (2021) · Nature Communications · doi:10.1038/s41467-021-25375-z · Cited by 102
A CRISPR/Cas9 toolkit for efficient targeted base editing to induce genetic variations in rice
Ren, B., Yan, F., Kuang, Y., Li, N., Zhang, D., Lin, H., & Zhou, H. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-0406-x · Cited by 102
CRISPR screens in plants: approaches, guidelines, and future prospects
Gaillochet, C., Develtere, W., & Jacobs, T. B. (2021) · The Plant Cell · doi:10.1093/plcell/koab099 · Cited by 102
Improving Nutritional and Functional Quality by Genome Editing of Crops: Status and Perspectives
Ku, H.-K., & Ha, S. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.577313 · Cited by 105
Hołubowicz, R., Du, S. W., Felgner, J. H., Šmidák, R., Choi, E. H., Palczewska, G., Menezes, C. R., Dong, Z., Gao, F., Medani, O., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01296-2 · Cited by 111
Self-citationGene therapy for visual loss: Opportunities and concerns
Lee, J. H., Wang, J.-H., Chen, J., Li, F., Edwards, T. L., Hewitt, A. W., & Liu, G. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.08.003 · Cited by 103
Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair
Wienert, B., Nguyen, D. N., Guenther, A., Feng, S. J., Locke, M. N., Wyman, S. K., Shin, J. J., Kazane, K. R., Gregory, G. L., Carter, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15845-1 · Cited by 102
Generating broad-spectrum tolerance to ALS-inhibiting herbicides in rice by base editing
Zhang, R., Chen, S., Meng, X., Chai, Z., Wang, D., Yuan, Y., Chen, K., Jiang, L., Li, J., & Gao, C. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1800-5 · Cited by 101
Suzuki, Y., Onuma, H., Sato, R., Sato, Y., Hashiba, A., Maeki, M., Tokeshi, M., Kayesh, M. E. H., Kohara, M., Tsukiyama–Kohara, K., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.013 · Cited by 102
Green Revolution to Gene Revolution: Technological Advances in Agriculture to Feed the World
Hamdan, M. F., Noor, S. N. M., Abd-Aziz, N., Pua, T., & Tan, B. C. (2022) · Plants · doi:10.3390/plants11101297 · Cited by 107
An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity
Wu, T., Liu, C., Zou, S., Lyu, R., Yang, B., Yan, H., Zhao, M., & Tang, W. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01380-9 · Cited by 104
Correction of muscular dystrophies by CRISPR gene editing
Chemello, F., Bassel‐Duby, R., & Olson, E. N. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136873 · Cited by 108
New variants of CRISPR RNA‐guided genome editing enzymes
Murovec, J., Pirc, Ž., & Yang, B. (2017) · Plant Biotechnology Journal · doi:10.1111/pbi.12736 · Cited by 102
Wang, G., Chow, R. D.-W., Ye, L., Guzman, C. D., Dai, X., Dong, M. B., Zhang, F., Sharp, P. A., Platt, R. J., & Chen, S. (2018) · Science Advances · doi:10.1126/sciadv.aao5508 · Cited by 101
Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
Cornet, C., Donato, V. D., & Terriente, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00703 · Cited by 106
Mashel, T. V., Tarakanchikova, Y. V., Muslimov, A. R., Zyuzin, M. V., Timin, A. S., Lepik, K. V., & Fehse, B. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120282 · Cited by 102
CRISPR-Based Genome Editing Tools: Insights into Technological Breakthroughs and Future Challenges
Mushtaq, M., Dar, A. A., Skalický, M., Tyagi, A., Bhagat, N., Basu, U., Bhat, B. A., Zaid, A., Ali, S., Dar, T. U. H., et al. (2021) · Genes · doi:10.3390/genes12060797 · Cited by 100
Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases
Lim, K., Cho, S.-I., & Kim, J. (2022) · Nature Communications · doi:10.1038/s41467-022-27962-0 · Cited by 100
The miniature CRISPR-Cas12m effector binds DNA to block transcription
Wu, W. Y., Mohanraju, P., Liao, C., Adiego-Pérez, B., Creutzburg, S. C. A., Makarova, K. S., Keessen, K., Lindeboom, T. A., Khan, T. S., Prinsen, S. H. P., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.11.003 · Cited by 102
Opportunities and Challenges for Molecular Understanding of Ciliopathies–The 100,000 Genomes Project
Wheway, G., Genomics England Research Consortium, & Mitchison, H. M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00127 · Cited by 99
Highly efficient and precise base editing by engineered dCas9-guide tRNA adenosine deaminase in rats
Ma, Y., Yu, L., Zhang, X., Xin, C., Huang, S., Bai, L., Chen, W., Gao, R., Li, J., Pan, S., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0047-9 · Cited by 103
Pazi, K., Chathoth, K. T., Taylor, G. C. A., Meynert, A. M., Ballinger, T. J., Kelder, M. J. E., Lalevée, S., Sanli, I., Feil, R., & Wood, A. J. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005595 · Cited by 99
Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing
Yang, Y.-C., Chen, Y., Kao, J., Ching, C., Liu, I.-J., Wang, C.-C., Tsai, C.-H., Wu, F., Liu, C., Chen, P., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.03.005 · Cited by 101
Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease
Ernst, M. P. T., Broeders, M., Herrero-Hernandez, P., Oussoren, E., van der Ploeg, A. T., & Pijnappel, W. W. M. P. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.022 · Cited by 103
Functional variomics and network perturbation: connecting genotype to phenotype in cancer
Yi, S. S., Lin, S., Li, Y., Zhao, W., Mills, G. B., & Sahni, N. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.8 · Cited by 105
Functional Genomics via CRISPR–Cas
Ford, K. M., McDonald, D., & Mali, P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.034 · Cited by 103
Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing
Maule, G., Arosio, D., & Cereseto, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113903 · Cited by 102
Masi, C. D., Spitalieri, P., Murdocca, M., Novelli, G., & Sangiuolo, F. C. (2020) · Human Genomics · doi:10.1186/s40246-020-00276-2 · Cited by 108
Nadakuduti, S. S., & Enciso-Rodríguez, F. E. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2020.637159 · Cited by 99
CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
Cheng, H., Zhang, F., & Ding, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101649 · Cited by 100
Base-editing mutagenesis maps alleles to tune human T cell functions
Schmidt, R. L. J., Ward, C. C., Dajani, R., Armour-Garb, Z., Ota, M., Allain, V., Hernandez, R., Layeghi, M., Xing, G., Goudy, L., et al. (2023) · Nature · doi:10.1038/s41586-023-06835-6 · Cited by 101
Kato-Inui, T., Takahashi, G., Hsu, S., & Miyaoka, Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky264 · Cited by 101
Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies
Magrin, E., Miccio, A., & Cavazzana, M. (2019) · Blood · doi:10.1182/blood.2019000949 · Cited by 100
Choi, E. H., Suh, S., Foik, A. T., Leinonen, H., Newby, G. A., Gao, X. D., Banskota, S., Hoang, T. V., Du, S. W., Dong, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29490-3 · Cited by 97
Self-citationRozas, P., Kessi‐Pérez, E. I., & Martı́nez, C. (2022) · Biological Research · doi:10.1186/s40659-022-00399-x · Cited by 99
A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing
Sichani, A. S., Ranjbar, M., Baneshi, M., Zadeh, F. T., & Fallahi, J. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00639-1 · Cited by 105
Tadić, V., Josipović, G., Zoldoš, V., & Vojta, A. (2019) · Methods · doi:10.1016/j.ymeth.2019.05.003 · Cited by 99
Engineering drought tolerance in plants through CRISPR/Cas genome editing
Joshi, R. K., Bharat, S. S., & Mishra, R. (2020) · 3 Biotech · doi:10.1007/s13205-020-02390-3 · Cited by 99
Chen, Q., Zhang, Y., & Yin, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.014 · Cited by 99
Newsom, S. N., Parameshwaran, H. P., Martin, L., & Rajan, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.619763 · Cited by 99
Prime editing with genuine Cas9 nickases minimizes unwanted indels
Lee, J., Lim, K., Kim, A., Mok, Y. G., Chung, E., Cho, S.-I., Lee, J. M., & Kim, J. (2023) · Nature Communications · doi:10.1038/s41467-023-37507-8 · Cited by 103
Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing
Yin, J., Lu, R., Xin, C., Wang, Y., Ling, X., Li, D., Zhang, W., Liu, M., Xie, W., Kong, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28900-w · Cited by 104
Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9
Schuler, G. A., Hu, C., & Ke, A. (2022) · Science · doi:10.1126/science.abq7220 · Cited by 95
CRISPR/Cas9 Landscape: Current State and Future Perspectives
Tyumentsev, A. I., Tyumentsev, A. I., & Акимкин, В. Г. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216077 · Cited by 98
Gene therapy clinical trials worldwide to 2023—an update
Ginn, S. L., Mandwie, M., Alexander, I. E., Edelstein, M. L., & Abedi, M. R. (2024) · The Journal of Gene Medicine · doi:10.1002/jgm.3721 · Cited by 100
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
Oakes, B. L., Fellmann, C., Rishi, H. S., Taylor, K. L., Ren, S. M., Nadler, D. C., Yokoo, R., Arkin, A. P., Doudna, J. A., & Savage, D. F. (2019) · Cell · doi:10.1016/j.cell.2018.11.052 · Cited by 94
Osborn, M. J., Newby, G. A., McElroy, A. N., Knipping, F., Nielsen, S. C., Riddle, M. J., Xia, L., Chen, W., Eide, C. R., Webber, B. R., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.07.701 · Cited by 100
Self-citationCRISPR in livestock: From editing to printing
Menchaca, A., dos Santos-Neto, P. C., Mulet, A. P., & Crispo, M. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.01.063 · Cited by 94
Li, C., Georgakopoulou, A., Mishra, A., Gil, S., Hawkins, R. D., Yannaki, E., & Lieber, A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003702 · Cited by 96
Next-Generation CRISPR Technologies and Their Applications in Gene and Cell Therapy
C., M. A. Z., & Gaj, T. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.10.010 · Cited by 99
Wannier, T. M., Ciaccia, P. N., Ellington, A. D., Filsinger, G. T., Isaacs, F. J., Javanmardi, K., Jones, M. A., Kunjapur, A. M., Nyerges, Á., Pál, C., et al. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-020-00006-x · Cited by 101
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Valeri, A., García-Ortiz, A., Castellano, E., Córdoba, L., Maroto-Martín, E., Encinas, J., Leivas, A., Río, P., & Martínez‐López, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953849 · Cited by 96
High-purity production and precise editing of DNA base editing ribonucleoproteins
Jang, H.-K., Jo, D. H., Lee, S.-N., Cho, C. S., Jeong, Y. K., Jung, Y., Yu, J., Kim, J. H., Woo, J.-S., & Bae, S. (2021) · Science Advances · doi:10.1126/sciadv.abg2661 · Cited by 93
Rational design of inducible CRISPR guide RNAs for de novo assembly of transcriptional programs
Ferry, Q. R. V., Lyutova, R., & Fulga, T. A. (2017) · Nature Communications · doi:10.1038/ncomms14633 · Cited by 93
Genome Editing: Past, Present, and Future.
Carroll, D. (2017) · PubMed Central · Cited by 93
Genome editing opens a new era of genetic improvement in polyploid crops
Zaman, Q. U., Li, C., Cheng, H., & Hu, Q. (2018) · The Crop Journal · doi:10.1016/j.cj.2018.07.004 · Cited by 93
Wang, Y., Wang, Z., Chen, Y., Hua, X., Yu, Y., & Ji, Q. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.09.003 · Cited by 94
Plant base editing and prime editing: The current status and future perspectives
Li, J., Zhang, C., He, Y., Li, S., Yan, L., Li, Y., Zhu, Z., & Xia, L. (2022) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13425 · Cited by 94
Base editing screens map mutations affecting interferon-γ signaling in cancer
Coelho, M. A., Cooper, S., Strauß, M. E., Karakoç, E., Bhosle, S. G., Gonçalves, E., Picco, G., Burgold, T., Cattaneo, C. M., Veninga, V., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2022.12.009 · Cited by 94
In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting
Chen, X., Janssen, J. M., Liu, J., Maggio, I., Jong, A. E. J. ‘., Mikkers, H. M. M., & Gonçalves, M. A. F. V. (2017) · Nature Communications · doi:10.1038/s41467-017-00687-1 · Cited by 92
Yoon, Y., Wang, D., Tai, P. W. L., Riley, J., Gao, G., & Rivera‐Pérez, J. A. (2018) · Nature Communications · doi:10.1038/s41467-017-02706-7 · Cited by 94
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
Carreras, A., Pane, L. S., Nitsch, R., Madeyski-Bengtson, K., Porritt, M. J., Akçakaya, P., Taheri‐Ghahfarokhi, A., Ericson, E., Bjursell, M., Pérez-Alcázar, M., et al. (2019) · BMC Biology · doi:10.1186/s12915-018-0624-2 · Cited by 93
Off-Target Editing by CRISPR-Guided DNA Base Editors
Park, S., & Beal, P. A. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00573 · Cited by 95
A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants
Kweon, J., Jang, A.-H., Shin, H. R., See, J.-E., Lee, W., Lee, J. W., Chang, S., Kim, K., & Kim, Y. (2019) · Oncogene · doi:10.1038/s41388-019-0968-2 · Cited by 93
Self-citation
Metadata
- Authors
- Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Liu, David R.
- Venue
- Nature
- Published
- 2016-04-20
- Volume
- 533
- Issue
- 7603
- Pages
- 420-424
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4873371
- OpenAlex
- W2336828812
- Cited by
- 5,437
- References
- 36
- Citations by year
- 2026: 564 · 2025: 660 · 2024: 664 · 2023: 719 · 2022: 681 · 2021: 614 · 2020: 540 · 2019: 408 · 2018: 338 · 2017: 182 · 2016: 61
- FWCI
- 171.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of General Medical Sciences (T32GM008313, F32 GM 106601-2, F32GM106601, F32 GM 112366-2, R01GM065400, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- base editing, CRISPR/Cas9, cytidine deaminase, point mutation correction, Cas9 nickase, DNA repair, guide RNA, genome editing, human disease models
- MeSH terms
- APOBEC-1 Deaminase, RNA, Guide, CRISPR-Cas Systems, Animals, Base Sequence, Cell Line, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, DNA Repair, Genetic Engineering, Humans, Templates, Genetic, Uridine, Genes, p53, Genome, Point Mutation, Mice, Uracil-DNA Glycosidase, Apolipoprotein E4, DNA Cleavage, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
